市場調査レポート
商品コード
1400442

咽喉癌治療薬の世界市場 2024-2028

Global Throat Cancer Therapeutics Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 158 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
咽喉癌治療薬の世界市場 2024-2028
出版日: 2023年12月15日
発行: TechNavio
ページ情報: 英文 158 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

咽喉癌治療薬市場は2023-2028年に23億3,000万米ドル、予測期間中のCAGRは7.51%で成長すると予測されます。

当レポートでは、咽喉癌治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。喉周りの癌罹患率の増加、タバコ製品の使用の増加、癌のリスク要因の増加などが市場を牽引しています。

市場範囲
基準年 2023
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 6.31%
CAGR 7.51%
増分額 23億3,000万米ドル

本調査では、今後数年間の咽喉癌治療薬市場の成長を牽引する主な要因として、ベンダーの戦略的提携の拡大を挙げています。また、咽喉癌治療薬の患者支援プログラムの導入増加や強力なパイプラインは、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 咽喉癌治療薬の世界市場 2018-2022
  • タイプセグメント分析 2018-2022
  • 流通チャネルセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 咽頭がん:市場規模と予測 2023-2028
  • 喉頭がん:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第7章 市場セグメンテーション:流通チャネル別

  • 市場セグメント
  • 比較:流通チャネル別
  • オフライン:市場規模と予測 2023-2028
  • オンライン:市場規模と予測 2023-2028
  • 市場機会:流通チャネル別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • インド:市場規模と予測 2023-2028
  • ハンガリー:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • ポーランド:市場規模と予測 2023-2028
  • 市場機会:地域別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Adlai Nortye Ltd.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Celldex Therapeutics Inc.
  • Clinigen Group Plc
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Merck KGaA
  • Moderna Inc
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Type ($ billion)
  • Exhibits43: Data Table on Market opportunity by Type ($ billion)
  • Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Distribution Channel
  • Exhibits47: Data Table on Comparison by Distribution Channel
  • Exhibits48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibits49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibits50: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Distribution Channel ($ billion)
  • Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share by geography 2023-2028 (%)
  • Exhibits60: Data Table on Market share by geography 2023-2028 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on Poland - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Market opportunity by geography ($ billion)
  • Exhibits100: Data Tables on Market opportunity by geography ($ billion)
  • Exhibits101: Impact of drivers and challenges in 2023 and 2028
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Adlai Nortye Ltd. - Overview
  • Exhibits108: Adlai Nortye Ltd. - Product / Service
  • Exhibits109: Adlai Nortye Ltd. - Key offerings
  • Exhibits110: Amgen Inc. - Overview
  • Exhibits111: Amgen Inc. - Product / Service
  • Exhibits112: Amgen Inc. - Key offerings
  • Exhibits113: AstraZeneca Plc - Overview
  • Exhibits114: AstraZeneca Plc - Product / Service
  • Exhibits115: AstraZeneca Plc - Key news
  • Exhibits116: AstraZeneca Plc - Key offerings
  • Exhibits117: Bayer AG - Overview
  • Exhibits118: Bayer AG - Business segments
  • Exhibits119: Bayer AG - Key news
  • Exhibits120: Bayer AG - Key offerings
  • Exhibits121: Bayer AG - Segment focus
  • Exhibits122: Bristol Myers Squibb Co. - Overview
  • Exhibits123: Bristol Myers Squibb Co. - Product / Service
  • Exhibits124: Bristol Myers Squibb Co. - Key news
  • Exhibits125: Bristol Myers Squibb Co. - Key offerings
  • Exhibits126: Celldex Therapeutics Inc. - Overview
  • Exhibits127: Celldex Therapeutics Inc. - Product / Service
  • Exhibits128: Celldex Therapeutics Inc. - Key offerings
  • Exhibits129: Clinigen Group Plc - Overview
  • Exhibits130: Clinigen Group Plc - Product / Service
  • Exhibits131: Clinigen Group Plc - Key offerings
  • Exhibits132: Eli Lilly and Co. - Overview
  • Exhibits133: Eli Lilly and Co. - Product / Service
  • Exhibits134: Eli Lilly and Co. - Key news
  • Exhibits135: Eli Lilly and Co. - Key offerings
  • Exhibits136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits141: Merck KGaA - Overview
  • Exhibits142: Merck KGaA - Business segments
  • Exhibits143: Merck KGaA - Key news
  • Exhibits144: Merck KGaA - Key offerings
  • Exhibits145: Merck KGaA - Segment focus
  • Exhibits146: Moderna Inc - Overview
  • Exhibits147: Moderna Inc - Product / Service
  • Exhibits148: Moderna Inc - Key offerings
  • Exhibits149: Novartis AG - Overview
  • Exhibits150: Novartis AG - Business segments
  • Exhibits151: Novartis AG - Key offerings
  • Exhibits152: Novartis AG - Segment focus
  • Exhibits153: Pfizer Inc. - Overview
  • Exhibits154: Pfizer Inc. - Product / Service
  • Exhibits155: Pfizer Inc. - Key news
  • Exhibits156: Pfizer Inc. - Key offerings
  • Exhibits157: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibits158: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibits159: Regeneron Pharmaceuticals Inc. - Key offerings
  • Exhibits160: Sanofi SA - Overview
  • Exhibits161: Sanofi SA - Business segments
  • Exhibits162: Sanofi SA - Key news
  • Exhibits163: Sanofi SA - Key offerings
  • Exhibits164: Sanofi SA - Segment focus
  • Exhibits165: Inclusions checklist
  • Exhibits166: Exclusions checklist
  • Exhibits167: Currency conversion rates for US$
  • Exhibits168: Research methodology
  • Exhibits169: Validation techniques employed for market sizing
  • Exhibits170: Information sources
  • Exhibits171: List of abbreviations
目次
Product Code: IRTNTR73577

Abstract

The throat cancer therapeutics market is forecasted to grow by USD 2.33 bn during 2023-2028, accelerating at a CAGR of 7.51% during the forecast period. The report on the throat cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of throat cancer, the growing use of tobacco products, and increasing risk factors for throat cancer.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.31%
CAGR7.51%
Incremental Value$2.33bn

Technavio's throat cancer therapeutics market is segmented as below:

By Type

  • Pharyngeal cancer
  • Laryngeal cancer

By Distribution Channel

  • Offline
  • Online

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing strategic alliances of the vendors as one of the prime reasons driving the throat cancer therapeutics market growth during the next few years. Also, rising adoption of patient assistance programs and strong pipeline of throat cancer therapeutics will lead to sizable demand in the market.

The report on the throat cancer therapeutics market covers the following areas:

  • Throat cancer therapeutics market sizing
  • Throat cancer therapeutics market forecast
  • Throat cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat cancer therapeutics market vendors that include Adlai Nortye Ltd., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Moderna Inc, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA. Also, the throat cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global throat cancer therapeutics market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
  • 4.2 Type Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 4.3 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Pharyngeal cancer - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
  • 6.4 Laryngeal cancer - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ billion)
  • Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel

  • 7.1 Market segments
  • Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 7.2 Comparison by Distribution Channel
  • Exhibit 46: Chart on Comparison by Distribution Channel
  • Exhibit 47: Data Table on Comparison by Distribution Channel
  • 7.3 Offline - Market size and forecast 2023-2028
  • Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • 7.4 Online - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Distribution Channel
  • Exhibit 56: Market opportunity by Distribution Channel ($ billion)
  • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
  • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 India - Market size and forecast 2023-2028
  • Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.9 Hungary - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
  • 9.10 Canada - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.11 Poland - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on Poland - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 99: Market opportunity by geography ($ billion)
  • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Adlai Nortye Ltd.
  • Exhibit 107: Adlai Nortye Ltd. - Overview
  • Exhibit 108: Adlai Nortye Ltd. - Product / Service
  • Exhibit 109: Adlai Nortye Ltd. - Key offerings
  • 12.4 Amgen Inc.
  • Exhibit 110: Amgen Inc. - Overview
  • Exhibit 111: Amgen Inc. - Product / Service
  • Exhibit 112: Amgen Inc. - Key offerings
  • 12.5 AstraZeneca Plc
  • Exhibit 113: AstraZeneca Plc - Overview
  • Exhibit 114: AstraZeneca Plc - Product / Service
  • Exhibit 115: AstraZeneca Plc - Key news
  • Exhibit 116: AstraZeneca Plc - Key offerings
  • 12.6 Bayer AG
  • Exhibit 117: Bayer AG - Overview
  • Exhibit 118: Bayer AG - Business segments
  • Exhibit 119: Bayer AG - Key news
  • Exhibit 120: Bayer AG - Key offerings
  • Exhibit 121: Bayer AG - Segment focus
  • 12.7 Bristol Myers Squibb Co.
  • Exhibit 122: Bristol Myers Squibb Co. - Overview
  • Exhibit 123: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 124: Bristol Myers Squibb Co. - Key news
  • Exhibit 125: Bristol Myers Squibb Co. - Key offerings
  • 12.8 Celldex Therapeutics Inc.
  • Exhibit 126: Celldex Therapeutics Inc. - Overview
  • Exhibit 127: Celldex Therapeutics Inc. - Product / Service
  • Exhibit 128: Celldex Therapeutics Inc. - Key offerings
  • 12.9 Clinigen Group Plc
  • Exhibit 129: Clinigen Group Plc - Overview
  • Exhibit 130: Clinigen Group Plc - Product / Service
  • Exhibit 131: Clinigen Group Plc - Key offerings
  • 12.10 Eli Lilly and Co.
  • Exhibit 132: Eli Lilly and Co. - Overview
  • Exhibit 133: Eli Lilly and Co. - Product / Service
  • Exhibit 134: Eli Lilly and Co. - Key news
  • Exhibit 135: Eli Lilly and Co. - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 Merck KGaA
  • Exhibit 141: Merck KGaA - Overview
  • Exhibit 142: Merck KGaA - Business segments
  • Exhibit 143: Merck KGaA - Key news
  • Exhibit 144: Merck KGaA - Key offerings
  • Exhibit 145: Merck KGaA - Segment focus
  • 12.13 Moderna Inc
  • Exhibit 146: Moderna Inc - Overview
  • Exhibit 147: Moderna Inc - Product / Service
  • Exhibit 148: Moderna Inc - Key offerings
  • 12.14 Novartis AG
  • Exhibit 149: Novartis AG - Overview
  • Exhibit 150: Novartis AG - Business segments
  • Exhibit 151: Novartis AG - Key offerings
  • Exhibit 152: Novartis AG - Segment focus
  • 12.15 Pfizer Inc.
  • Exhibit 153: Pfizer Inc. - Overview
  • Exhibit 154: Pfizer Inc. - Product / Service
  • Exhibit 155: Pfizer Inc. - Key news
  • Exhibit 156: Pfizer Inc. - Key offerings
  • 12.16 Regeneron Pharmaceuticals Inc.
  • Exhibit 157: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibit 158: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibit 159: Regeneron Pharmaceuticals Inc. - Key offerings
  • 12.17 Sanofi SA
  • Exhibit 160: Sanofi SA - Overview
  • Exhibit 161: Sanofi SA - Business segments
  • Exhibit 162: Sanofi SA - Key news
  • Exhibit 163: Sanofi SA - Key offerings
  • Exhibit 164: Sanofi SA - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 165: Inclusions checklist
  • Exhibit 166: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 167: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 168: Research methodology
  • Exhibit 169: Validation techniques employed for market sizing
  • Exhibit 170: Information sources
  • 13.5 List of abbreviations
  • Exhibit 171: List of abbreviations